Why CAMP4?
Leadership
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Investors
Newsroom
Join the Adventure
Recent News
October 11, 2024
Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO
Read More
Contact Us
Privacy Policy
Terms of Use
Menu
Newsroom
Views and missives from the frontier
All
Perspectives
In the News
Videos
In the News
/
July 22, 2022
CAMP4 Raises $100M to Drug ‘the Dark Side of the Genome’
Download PDF
Top
